Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):199-203.

Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis.

Author information

1
Department of Neurology, Teikyo University School of Medicine, Ichihara Hospital, Ichihara, Japan.

Abstract

OBJECTIVES:

Insulin-like growth factor I (IGF-I) has potent effects on motor neuron survival and is being studied as a possible therapeutic agent for ALS. However, little is known concerning IGF-I in the skin of patients with amyotrophic lateral sclerosis (ALS). The aim was to evaluate IGF-I immunoreactivity of skin in patients with ALS.

METHODS:

IGF-I immunoreactivity of skin from 18 patients with ALS and 16 controls was examined.

RESULTS:

IGF-I immunoreactivity was markedly positive in the epidermis and dermal blood vessels and glands and was moderately positive in the reticular dermis in all patients with ALS. On the other hand, the epidermis and dermal blood vessels and glands and the reticular dermis showed a weak IGF-I immunoreactivity in controls. The optical density for IGF-I immunoreactivity of the epidermis and dermal blood vessels and glands, and the reticular dermis in patients with ALS was significantly higher than in diseased controls, and was significantly increased with duration of illness.

CONCLUSIONS:

These data suggest that a metabolic alteration of IGF-I may take place in the skin of patients with ALS.

PMID:
10896693
PMCID:
PMC1737075
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center